MacroGenics, Inc.MGNXNASDAQ

Revenue (LTM)

$150M

+0.8% YoY

Net Income (LTM)

$-75M

-11.4% YoY

Free Cash Flow

$-83M

Revenue CAGR (5Y)

+18.6%

Marginsdeclining

FCF($0.1B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	76	150↑98.3%	57↓61.9%	148↑159.4%	150↑0.8%
Gross Profit	73	143↑95.4%	49↓65.7%	136↑177.8%	106↓21.8%
Operating Income	-203	-121↑40.1%	-168↓38.6%	-111↑34.3%	-73↑34.1%
Net Income	-202	-120↑40.7%	-9↑92.4%	-67↓639.3%	-75↓11.4%
EBITDA	-191	-108↑43.5%	2↑101.9%	-57↓2944.2%	-66↓14.5%
EPS Diluted	-3.18	-1.95↑38.7%	-0.15↑92.3%	-1.07↓613.3%	-1.18↓10.3%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	123	109↓11.8%	101↓7.3%	183↑81.1%	57↓68.7%
Total Current Assets	280	222↓20.5%	251↑13.1%	217↓13.5%	220↑1.1%
Total Assets	335	290↓13.6%	298↑3.1%	262↓12.3%	257↓1.8%
Total Current Liabilities	75	49↓34.8%	56↑15.4%	56↓1.0%	43↓22.4%
Total Liabilities	96	147↑54.2%	146↓1.1%	146↓0.1%	201↑38.2%
Total Equity	240	142↓40.7%	153↑7.5%	116↓24.0%	56↓52.1%
Total Debt	25	35↑36.8%	34↓2.5%	37↑10.3%	107↑185.0%
Net Debt	-98	-74↑24.4%	-67↑9.5%	-145↓117.0%	50↑134.1%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-144	-87↑39.5%	-78↑10.1%	-68↑12.6%	-81↓18.5%
Capital Expenditure	-6	-4↑41.6%	-2↑51.3%	-4↓110.1%	-2↑48.4%
Free Cash Flow	-150	-91↑39.6%	-80↑11.7%	-72↑9.9%	-83↓15.1%
Stock-Based Comp	23	20↓11.6%	18↓10.1%	29↑60.2%	14↓51.5%
Net Change in Cash	-58	-15↑74.7%	-8↑45.6%	82↑1132.8%	-126↓253.4%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance